MORGAN CROWE SWEENEY: Open Payments
NPI 1184367468 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 21 payments from 12 companies in 2025. Trend: 2023 $407 · 2024 $531 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $193 |
| PFIZER INC. | 3 | $56 |
| Abbott Laboratories | 2 | $38 |
| ABBVIE INC. | 2 | $32 |
| TOLMAR, INC. | 1 | $27 |
| Novo Nordisk Inc | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Recor Medical Inc | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: BREZTRI, FARXIGA, PREVNAR 20, FREESTYLE LIBRE 3, VRAYLAR, JATENZO, Rybelsus, KRYSTEXXA.
Industry payments across SC — which companies pay providers there.
